Vague Takeover Chatter Regarding Cephalon (CEPH)

Loading...
Loading...
There is some vague chatter on Wall Street today about Cephalon
CEPH
possibly being the target of a takeover. The suitors that have been mentioned in the past include Pfizer
PFE
and in particular Takeda Pharmaceutical. Cephalon (
CEPH
) is trading well off of its lows for the day, but remains in negative territory. Currently the shares have shed 0.81% and are exchanging hands for $60.28. Even if an offer does not materialize, CEPH looks rather cheap at less than 8 times forward earnings and a PEG ratio of 0.83.
Posted In: NewsRumorsM&AIntraday UpdateBiotechnologyHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...